PMID: 7547700May 1, 1995Paper

Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera

International Immunology
T SeyaJ P Atkinson

Abstract

Normal human sera contained 10-60 ng/ml of soluble membrane cofactor protein (MCP, CD46) whereas sera of > 50% of the cancer patients contained > 60 ng/ml. MCP purified by immunoaffinity chromatography from both normal and cancer patients' sera consisted of three bands of 56, 47 and 29 kDa on SDS-PAGE/immunoblotting. The upper two components were increased in cancer patient sera. The 56 and 47 kDa soluble forms served as a cofactor for factor I-mediated cleavage of C3b. MCP expressed on Chinese hamster ovary (CHO) cells protects host cells from human C3 deposition and complement-mediated cytolysis, especially by activation of the alternative pathway. In this same assay system, exogenously added soluble MCP also protected untransfected CHO cells; however, its potency was much less than that of the endogenous membrane form. For example, 8 micrograms/ml of soluble MCP was equal to 10(4) copies/cell of the expressed MCP. Recombinant soluble forms possessed similar activity to the naturally occurring soluble forms and high doses (> 150 micrograms) blocked Arthus-like reaction induced in guinea-pigs by anti-Forssman antibody. These data establish that soluble forms of MCP are present in human sera that possess cofactor activity and t...Continue Reading

Citations

Jan 27, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Siobhan Ni Choileain, Anne L Astier
Oct 1, 1996·Journal of Reproductive Immunology·P J McLaughlinP M Johnson
Oct 15, 2013·The International Journal of Biochemistry & Cell Biology·Hidekazu YamamotoClaudia Kemper
Mar 4, 2000·Molecular Immunology·K JurianzM Kirschfink
Feb 24, 2001·Clinical and Experimental Immunology·E CocuzziM E Medof
Nov 10, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L ThorsteinssonP M Johnson
Apr 14, 2016·Molecular Therapy. Methods & Clinical Development·Maximilian RichterAndré Lieber
Jul 12, 2011·Immunobiology·Siobhan Ni Choileain, Anne L Astier
Dec 24, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Roberto Alvarez-LafuenteRafael Arroyo
Aug 25, 2004·Trends in Immunology·Rebecca C Riley-VargasJohn P Atkinson
Jan 9, 2004·International Journal of Cancer. Journal International Du Cancer·Neil K RushmereRobert I Nicholson
Jun 1, 2006·The Journal of Biological Chemistry·Juha Hakulinen, Jorma Keski-Oja
Nov 6, 2020·Antibodies·Michelle ElvingtonJohn P Atkinson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.